Stewart Jeffrey Ryan

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 68% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Stewart Jeffrey Ryan's trades of Abbvie Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
349.98
Quantity 96,186 -49.3%
Value US$1,471,037
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
94.07
Quantity 37,411 +4.6%
Value US$1,200,941
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
121.28
Quantity 52,964 +4.3%
Value US$3,014,036
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
179.03
Quantity 5,099 -5.4%
Value US$912,874
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
178.85
Quantity 26,110 -21.8%
Value US$4,669,774
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
178.80
Quantity 58,949
Value US$10,539,878
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
152.27
Quantity 31,315 -33.9%
Value US$4,768,335
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
152.30
Quantity 21,810 -19.1%
Value US$3,321,663
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
159.20
Quantity 27,690 -31.2%
Value US$4,408,375
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
149.04
Quantity 2,600 -4.1%
Value US$387,493
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
148.49
Quantity 12,659 -16.6%
Value US$1,879,779
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
147.43
Quantity 6,229 -7.6%
Value US$918,327
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
128.00
Quantity 2,152 -4.4%
Value US$275,456
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
108.59
Quantity 13,773 -21.3%
Value US$1,495,576
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
90.00
Quantity 23,024 -30.4%
Value US$2,072,211
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-02 2025-03-31
US Abbvie Inc (ABBV)
S Sale
96,186 -49.3%
349.98
US$1,471,037 		96,186 -49.3% 349.98 US$1,471,037
2025-04-02 2025-03-31
US Abbvie Inc (ABBV)
S Sale
37,411 +4.6%
94.07
US$1,200,941 		37,411 +4.6% 94.07 US$1,200,941
2024-03-20 2024-03-18
US Abbvie Inc (ABBV)
S Sale
52,964 +4.3%
121.28
US$3,014,036 		52,964 +4.3% 121.28 US$3,014,036
2024-03-20 2024-03-18
US Abbvie Inc (ABBV)
S Sale
5,099 -5.4%
179.03
US$912,874 		5,099 -5.4% 179.03 US$912,874
2024-03-20 2024-03-18
US Abbvie Inc (ABBV)
S Sale
26,110 -21.8%
178.85
US$4,669,774 		26,110 -21.8% 178.85 US$4,669,774
2024-03-18 2024-03-18
US Abbvie Inc (ABBV)
PrS Proposed sale
58,949
178.80
US$10,539,878 		58,949 178.80 US$10,539,878
2023-03-15 2023-03-13
US Abbvie Inc (ABBV)
S Sale
31,315 -33.9%
152.27
US$4,768,335 		31,315 -33.9% 152.27 US$4,768,335
2023-03-15 2023-03-13
US Abbvie Inc (ABBV)
S Sale
21,810 -19.1%
152.30
US$3,321,663 		21,810 -19.1% 152.30 US$3,321,663
2022-03-25 2022-03-24
US Abbvie Inc (ABBV)
S Sale
27,690 -31.2%
159.20
US$4,408,375 		27,690 -31.2% 159.20 US$4,408,375
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
2,600 -4.1%
149.04
US$387,493 		2,600 -4.1% 149.04 US$387,493
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
12,659 -16.6%
148.49
US$1,879,779 		12,659 -16.6% 148.49 US$1,879,779
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
6,229 -7.6%
147.43
US$918,327 		6,229 -7.6% 147.43 US$918,327
2021-12-17 2021-12-15
US Abbvie Inc (ABBV)
S Sale
2,152 -4.4%
128.00
US$275,456 		2,152 -4.4% 128.00 US$275,456
2021-03-02 2021-03-01
US Abbvie Inc (ABBV)
S Sale
13,773 -21.3%
108.59
US$1,495,576 		13,773 -21.3% 108.59 US$1,495,576
2020-05-12 2020-05-12
US Abbvie Inc (ABBV)
S Sale
23,024 -30.4%
90.00
US$2,072,211 		23,024 -30.4% 90.00 US$2,072,211